SAM
PFE icon

Smithbridge Asset Management’s Pfizer PFE Stock Holding History

Smithbridge Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,564
Closed -$338K – 198
2025
Q4 		$338K Buy
+13,564
New +$342K 0.03% 158
2022
Q3 		– Sell
-6,337
Closed -$332K – 100
2022
Q2 		$332K Buy
+6,337
New +$323K 0.13% 86
2022
Q1 		– Sell
-3,857
Closed -$228K – 109
2021
Q4 		$228K Buy
+3,857
New +$191K 0.07% 105

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Smithbridge Asset Management's PFE Position: Q1 2026 in Review

Smithbridge Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 13,564 shares — an estimated $338K sold.

Smithbridge Asset Management first reported a position in PFE in Q4 2021 and held it in 3 quarters. The position peaked at $338K in Q4 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Smithbridge Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Smithbridge Asset Management sold 13,564 Pfizer shares in Q1 2026, an estimated $338K.
  • Smithbridge Asset Management first reported a position in Pfizer in Q4 2021 and held it in 3 quarters.
  • Smithbridge Asset Management's Pfizer position peaked at $338K in Q4 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Smithbridge Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.